“GSK was prejudiced by not being allowed to present this evidence to the jury to show that Mr. Dolin committed suicide because of his underlying anxiety and depression, which was heavily influenced by the stress and pressure he felt at work," company lawyers argued. Here's a look at what their expert would have said.
September 18, 2017 at 12:04 AM
1 minute read
There will be no new trial for GlaxoSmithKline in connection with the death of Reed Smith partner Stewart Dolin in 2010, a federal judge in Chicago ruled last week.
The company, which was hit with a $3 million verdict earlier this year, was sued by the widow of Stewart Dolin, who threw himself in front of an “L” train shortly after he began taking a generic version of GSK’s antidepressant Paxil.
Presented by BigVoodoo
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Law firms & in-house legal departments with a presence in the middle east celebrate outstanding achievement within the profession.
The premier educational and networking event for employee benefits brokers and agents.
Atlanta s John Marshall Law School is seeking to hire one or more full-time, visiting Legal WritingInstructors to teach Legal Research, Anal...
Lower Manhattan firm seeks a premises liability litigator (i.e., depositions, SJ motions, and/or trials) with at least 3-6 years of experien...
Join the Mendocino County District Attorney s Office and work in Mendocino County home to redwoods, vineyards and picturesque coastline. ...
MELICK & PORTER, LLP PROMOTES CONNECTICUT PARTNERS HOLLY ROGERS, STEVEN BANKS, and ALEXANDER AHRENS
